Tracking of new avian influenza viruses becomes possible through modern analyses of genome data

11-Aug-2020 - An international consortium succeeded in tracking the genesis and spread of new reassortants of avian influenza viruses by the use of mathematical analyses. This large-scale international study has now been published in the scientific journal PNAS (Proceedings of the National Academy of Sciences ...

New Consortium Paves the way for Improved Treatment of Hypertension and Associated Vascular Complications

20-Nov-2009 - Top Institute Pharma has formed a consortium with Actelion Pharmaceuticals Ltd, Erasmus Medical Centre and Maastricht University to define new modalities for the treatment of hypertension and associated vascular complications such as heart and kidney failure, myocardial infarction and stroke. ...

Scientists Discover New Molecular Markers for Testicular Cancer

Researchers in the Netherlands use new technology from Applied Biosystems to identify different expression patterns of microRNA molecules in normal and cancerous cells

18-Oct-2007 - Scientists at the Erasmus MC-University Medical Center in Rotterdam, The Netherlands and Applied Biosystems, an Applera Corporation business, have made significant advances in testicular cancer research by identifying and analyzing a set of specific microRNA molecular markers that are involved in ...

European expert consortium combines forces to develop a novel pandemic influenza vaccine

28-Sep-2007 - A consortium of experts in the field of human virus research and vaccine development have joined forces to develop a novel pandemic influenza vaccine as a potential emergency vaccination. The four-year project has been awarded a grant of EUR3.5 million from the European Union to help fund the ...

OncoMethylome Publishes Positive Clinical Trial Results for Urine-based Bladder Cancer Test

19-Sep-2007 - OncoMethylome Sciences published interim data from its ongoing bladder cancer clinical trial. The trial results showed that the urine test that OncoMethylome is developing can successfully detect bladder cancer, especially when the cancer is in early stages of its development and most difficult ...

DNage, Loders Croklaan, BG Medicine and Erasmus announce collaboration in the field of type II diabetes

02-May-2006 - DNage BV, Loders Croklaan BV, through its wholly owned subsidiary Lipid Nutrition BV ("Lipid Nutrition"), BG Medicine Inc ("BG Medicine") and the Erasmus University Medical Center ("Erasmus MC") announced the start of a collaboration to develop new products and biomarkers for type II diabetes. A ...

DakoCytomation and ViroNovative enter licensing agreement on Human Metapneumovirus

09-May-2005 - DakoCytomation A/S and ViroNovative BV have entered into a licensing agreement for the development and sales of diagnostic products for the detection of Human Metapneumovirus. Human metapneumovirus was discovered by a team of scientists led by Prof. Dr. Ab Osterhaus at the Erasmus Medical ...